PDS Biotechnology Corp Files 8-K
Ticker: PDSB · Form: 8-K · Filed: May 8, 2025 · CIK: 1472091
| Field | Detail |
|---|---|
| Company | Pds Biotechnology Corp (PDSB) |
| Form Type | 8-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-update
TL;DR
PDS Biotech filed an 8-K on May 8, 2025, likely containing routine updates or exhibits.
AI Summary
On May 8, 2025, PDS Biotechnology Corporation filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events or financial figures detailed in the provided text. The company is incorporated in Delaware and headquartered in Princeton, NJ.
Why It Matters
This 8-K filing indicates that PDS Biotechnology Corporation is providing updates or submitting required documentation to the SEC, which could contain important operational or financial information for investors.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing header and does not contain specific material events or financial data that would indicate a high-risk situation.
Key Numbers
- 001-37568 — SEC File Number (Identifies the company's filing with the SEC.)
- 26-4231384 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- PDS Biotechnology Corporation (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Princeton, NJ (location) — Principal Executive Offices
- Edge Therapeutics, Inc. (company) — Former Company Name
FAQ
What specific 'Other Events' are reported in this 8-K filing?
The provided text for the 8-K filing does not detail the specific 'Other Events' being reported, only that this item is included.
Are there any significant financial statements or exhibits attached to this filing?
The filing indicates 'Financial Statements and Exhibits' are included, but the content of these documents is not provided in the excerpt.
When was PDS Biotechnology Corporation incorporated?
The filing states the company is incorporated in Delaware.
What is the primary business address of PDS Biotechnology Corporation?
The principal executive offices are located at 303A College Road East, Princeton, NJ 08540.
Has PDS Biotechnology Corporation undergone a name change?
Yes, the company was formerly known as Edge Therapeutics, Inc., with a name change date of September 11, 2009.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding PDS Biotechnology Corp (PDSB).